Olanzapine can worsen parkinsonism

被引：52

作者：

Jiménez-Jiménez, FJ

Tallón-Barranco, A

Ortí-Pareja, M

Zurdo, M

Porta, J

Molina, JA

机构：

[1] Univ Alcala de Henares, Hosp Principe Asturias, Dept Neurol, Madrid, Spain

[2] Univ Madrid, Hosp 12 Octubre, Madrid 3, Spain

来源：

NEUROLOGY | 1998年 / 50卷 / 04期

关键词：

D O I：

10.1212/WNL.50.4.1183-a

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：1183 / 1184

页数：2

共 7 条

[1] Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha(1)-adrenergic and muscarinic receptors in vivo in rats [J].

Bymaster, FP ;

HemrickLuecke, SK ;

Perry, KW ;

Fuller, RW .

PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :87-94

[2] Cenesthetic hallucinations in a patient with Parkinson's disease [J].

JimenezJimenez, FJ ;

OrtiPareja, M ;

Gasalla, T ;

TallonBarranco, A ;

CabreraValdivia, F ;

FernandezLliria, A .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (01) :120-120

[3]

Owens DGC, 1996, DRUGS, V51, P895

[4] Dopamine D-2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine - A I-123 IBZM single photon emission tomography (SPET) study [J].

Pilowsky, LS ;

Busatto, GF ;

Taylor, M ;

Costa, DC ;

Sharma, T ;

Sigmundsson, T ;

Ell, PJ ;

Nohria, V ;

Kerwin, RW .

PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :148-153

[5] LOW-DOSE CLOZAPINE IN THE TREATMENT OF LEVODOPA-INDUCED MENTAL DISTURBANCES IN PARKINSONS-DISEASE [J].

RABEY, JM ;

TREVES, TA ;

NEUFELD, MY ;

ORLOV, E ;

KORCZYN, AD .

NEUROLOGY, 1995, 45 (03) :432-434

[6]

SAINTCYR JA, 1993, NEUROLOGY, V43, P47

[7] Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease [J].

Wolters, EC ;

Jansen, ENH ;

TuynmanQua, HG ;

Bergmans, PLM .

NEUROLOGY, 1996, 47 (04) :1085-1087

← 1 →